Alliança Saúde e Participações S.A. (BVMF:AALR3)
Brazil · Delayed Price · Currency is BRL 3.040
-0.050 (-1.62%)
Aug 6, 2026, 5:03 PM GMT-3
BVMF:AALR3 Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,154 | 1,217 | 1,180 | 1,085 | 1,137 | |
Revenue Growth | -5.19% | 3.17% | 8.72% | -4.54% | 22.37% |
Cost of Revenue | 914.29 | 861.34 | 814.78 | 759.26 | 780.53 |
Gross Profit | 239.54 | 355.66 | 364.8 | 325.75 | 356.04 |
Selling, General & Admin | 292.51 | 248.6 | 325.08 | 338.41 | 261.93 |
Other Operating Expenses | 989.44 | -5.95 | 6.98 | 30.45 | 11.89 |
Operating Expenses | 1,282 | 242.65 | 332.06 | 368.86 | 273.82 |
Operating Income | -1,042 | 113.01 | 32.75 | -43.12 | 82.22 |
Interest Expense | -233.16 | -208.46 | -238.37 | -201.2 | -85.72 |
Earnings From Equity Investments | - | - | 6.16 | 11.08 | 5.95 |
Pretax Income | -1,276 | -95.45 | -199.47 | -233.23 | 2.46 |
Income Tax Expense | 84.16 | 21.79 | 19.09 | -13.99 | 0.47 |
Earnings From Continuing Operations | -1,360 | -117.24 | -218.56 | -219.24 | 1.99 |
Earnings From Discontinued Operations | -12.1 | - | - | - | - |
Net Income to Company | -1,372 | -117.24 | -218.56 | -219.24 | 1.99 |
Minority Interest in Earnings | -0.51 | -11.88 | -9.32 | -8.57 | -7.61 |
Net Income | -1,372 | -129.12 | -227.88 | -227.81 | -5.63 |
Net Income to Common | -1,372 | -129.12 | -227.88 | -227.81 | -5.63 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | - | 118 | 118 | 118 | 117 |
Shares Outstanding (Diluted) | - | 118 | 118 | 118 | 117 |
Shares Change | - | - | 0.43% | 0.52% | -0.72% |
EPS (Basic) | - | -1.09 | -1.93 | -1.93 | -0.05 |
EPS (Diluted) | - | -1.09 | -1.93 | -1.93 | -0.05 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 122.84 | -140.41 | 10.78 | 74.29 | 48.64 |
Free Cash Flow Per Share | - | -1.19 | 0.09 | 0.63 | 0.41 |
Gross Margin | 20.76% | 29.22% | 30.93% | 30.02% | 31.33% |
Operating Margin | -90.34% | 9.29% | 2.78% | -3.97% | 7.23% |
Profit Margin | -118.94% | -10.61% | -19.32% | -21.00% | -0.50% |
Free Cash Flow Margin | 10.65% | -11.54% | 0.91% | 6.85% | 4.28% |
EBITDA | -952.3 | 164.9 | 71.52 | 74.62 | 201.83 |
EBITDA Margin | -82.53% | 13.55% | 6.06% | 6.88% | 17.76% |
D&A For EBITDA | 90.11 | 51.89 | 38.77 | 117.74 | 119.6 |
EBIT | -1,042 | 113.01 | 32.75 | -43.12 | 82.22 |
EBIT Margin | -90.34% | 9.29% | 2.78% | -3.97% | 7.23% |
Effective Tax Rate | - | - | - | - | 19.05% |